when do compounding pharmacies have to stop making semaglutide π¨ FDA Moves Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these US FDA proposes curbs on
Description
A number of digital health companies, including Ro, Noom, 23andMe, WeightWatchers, Calibrate, Sesame and Hims & Hers along with telehealth giant Teladoc, have launched weight loss programs to support the management of GLP-1s or now offer access to obesity medications

Accelerated schedules exist but carry higher side-effect risk

The agency has also identified outright fraudulent products, vials with labels listing pharmacies that either do not exist or did not actually make the product
Holotranscobalamin (active B12) where available, this is a more sensitive early marker of B12 depletion and may be preferred in some settings [12] [15] Full blood count to identify macrocytosis or anaemia Folate levels as folate deficiency can co-exist and confound the clinical picture Methylmalonic acid (MMA) and homocysteine functional markers of B12 status, useful when serum B12 is borderline

Needles must be sharp and sterile to minimize pain and prevent infections

While both are potent medications, they work in slightly different ways
